Role of Trop2, Cyclin D1 and FOXP3 in bladder carcinoma in Egyptian patients: An immunohistochemical study

Evaluation of pyruvate kinase M2 (PKM2) and epidermal growth factor receptor (EGFR) expression and their clinicopathologic significance in bladder urothelial carcinoma

Evaluation of CK903 and P40 in distinguishing questionable prostatic lesions

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

Role of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study

Bladder Cancer Molecular Classification: Current Status and Future Prospects.

Prognostic role of CHEK2, FASN and Her2/neu Expression in Stage Ta-T1 Non-Muscle-Invasive Bladder Cancer (NMIBC)

Evaluation the expression of Sp1 and Par3 in urinary bladder carcinoma

Comparative study of BAP1 and CD147 expression in the diagnosis of malignant mesothelioma